
GoodRx Holdings GDRX
€ 2.48
0.0%
Quartalsbericht 2026-Q1
hinzugefügt 06.05.2026
GoodRx Holdings Operativer Cashflow 2011-2026 | GDRX
Operativer Cashflow Jährlich GoodRx Holdings
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 168 M | 184 M | 138 M | 147 M | 179 M | 131 M | 83.3 M | 45.3 M | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 184 M | 45.3 M | 134 M |
Operativer Cashflow Vierteljährlich GoodRx Holdings
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 11.8 M | - | - | 9.41 M | - | - | 42.6 M | - | - | 32.3 M | - | - | 81.2 M | 30.1 M | - | - | 80.4 M | 45.5 M | - | 116 M | 83.8 M | 45.6 M | - | 66.8 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 116 M | 9.41 M | 53.8 M |
Operativer Cashflow anderer Aktien in der Gesundheitsdienste
| Name | Operativer Cashflow | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Evolent Health
EVH
|
38.8 M | $ 4.18 | - | $ 477 M | ||
|
Accolade
ACCD
|
-25.2 M | - | 0.29 % | $ 206 M | ||
|
Cerner Corporation
CERN
|
1.77 B | - | - | $ 27.9 B | ||
|
Change Healthcare
CHNG
|
697 M | - | - | $ 9.03 B | ||
|
Computer Programs and Systems
CPSI
|
37 M | - | 4.4 % | $ 133 M | ||
|
Covetrus
CVET
|
102 M | - | - | $ 2.94 B | ||
|
HealthEquity
HQY
|
457 M | $ 84.84 | - | $ 7.31 B | ||
|
iCAD
ICAD
|
-3.94 M | - | - | $ 102 M | ||
|
Akerna Corp.
KERN
|
-79.6 M | - | - | $ 161 M | ||
|
10x Genomics
TXG
|
-15.2 M | $ 21.6 | - | $ 2.53 B | ||
|
Allscripts Healthcare Solutions
MDRX
|
-75.4 M | - | -10.39 % | $ 886 M | ||
|
MTBC
MTBC
|
28.6 M | - | -0.58 % | $ 51.7 M | ||
|
1Life Healthcare
ONEM
|
-88.6 M | - | - | $ 3.37 B | ||
|
NextGen Healthcare
NXGN
|
98.5 M | - | - | $ 1.6 B | ||
|
Premier
PINC
|
401 M | - | - | $ 2.33 B | ||
|
Health Catalyst
HCAT
|
731 K | $ 1.52 | - | $ 106 M | ||
|
OptimizeRx Corporation
OPRX
|
-7.24 M | $ 6.44 | - | $ 110 M | ||
|
Schrödinger
SDGR
|
13.9 M | $ 13.13 | - | $ 964 M | ||
|
Phreesia
PHR
|
78.8 M | $ 10.17 | - | $ 608 M | ||
|
R1 RCM
RCM
|
265 M | - | - | $ 3.81 B | ||
|
Teladoc Health
TDOC
|
294 M | $ 7.25 | - | $ 1.28 B | ||
|
Signify Health
SGFY
|
41.7 M | - | -0.02 % | $ 7.21 B | ||
|
Streamline Health Solutions
STRM
|
-1.51 M | - | - | $ 21.4 M | ||
|
NantHealth
NH
|
-32.3 M | - | -46.64 % | $ 10.4 M | ||
|
SCWorx Corp.
WORX
|
-1.54 M | - | - | $ 7.71 M | ||
|
American Well Corporation
AMWL
|
-66 M | $ 7.97 | 3.17 % | $ 128 M | ||
|
Tabula Rasa HealthCare
TRHC
|
7.36 M | - | - | $ 255 M | ||
|
HealthStream
HSTM
|
63.3 M | $ 23.96 | - | $ 719 M | ||
|
Omnicell
OMCL
|
127 M | $ 43.82 | - | $ 2.01 B | ||
|
Progyny
PGNY
|
210 M | $ 23.72 | - | $ 2.02 B | ||
|
So-Young International
SY
|
-105 M | $ 2.97 | - | $ 231 M | ||
|
Veeva Systems
VEEV
|
1.42 B | $ 166.34 | - | $ 27.2 B | ||
|
Zhongchao
ZCMD
|
845 K | $ 1.58 | - | $ 5.4 M |